Telehealth and Telemedicine in Latin American Rheumatology, a New Era After COVID-19

J Clin Rheumatol. 2023 Apr 1;29(3):165-169. doi: 10.1097/RHU.0000000000001968.

Abstract

Telemedicine is the delivery of health care services by health care professionals using information and communication technologies to exchange valid information for the diagnosis, treatment, and prevention of diseases. Telemedicine was further developed in Latin America during the COVID-19 (coronavirus disease 2019) pandemic, becoming the first line of defense for health professionals to stop the spread of infections and allow them to continue the care of their patients. During the pandemic, 79% of rheumatologists in Latin America reported the use of remote communication, the most frequent being the use of phone calls and WhatsApp voice messages. In contrast, 84% of the patients reported that telemedicine was appropriate for them during the pandemic, but only 54% considered telemedicine to be a valid option for rheumatic health care after the pandemic. Telemedicine and telehealth have advantages such as lower costs, improved access in rural areas, shortage of care providers, and reduction in waiting time for appointments. However, it also has some challenges, such as legal, technological, and organizational barriers. In this review, we explore the current state of telemedicine in Latin America and discuss its future.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Humans
  • Latin America / epidemiology
  • Rheumatology*
  • SARS-CoV-2
  • Telemedicine*